Unnikrishnan, A., Deshpande, N., Verma, A., Kumari, A., Richards, L., Knezevic, K., . . . Pimanda, J. (2017). Integrative genomics identifies the molecular basis of resistance to azacitidine therapy in myelodysplastic syndromes. Cell Press.
Chicagoスタイル(17版)引用形式Unnikrishnan, A., et al. Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes. Cell Press, 2017.
MLA(9版)引用形式Unnikrishnan, A., et al. Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes. Cell Press, 2017.
警告: この引用は必ずしも正確ではありません.